← All Sponsors
SPONSOR

Iksuda Therapeutics Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1
Conditions studied: B-cell Non-Hodgkin LymphomaDiffuse Large B Cell LymphomaFollicular LymphomaMantle Cell LymphomaB-cell Lymphoma
NCT05365659 Phase 1
Recruiting

IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas

B-cell Non-Hodgkin Lymphoma
United States, Australia, Canada View Trial →